C4 Therapeutics, Inc. 10-K filing
Filed 2026-02-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001628280-26-012000
- Form type
- 10-K
- CIK
- 0001662579
- Primary document
- https://www.sec.gov/Archives/edgar/data/1662579/000162828026012000/cccc-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for C4 Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $35.9M | - | - |
| Operating Income | $-115.2M | - | - |
| Net Income | $-105.0M | - | - |
| Eps Basic | -1.27 | - | - |
| Eps Diluted | -1.27 | - | - |
| Cash And Equivalents | $74.6M | - | - |
| Total Assets | $359.1M | - | - |
| Total Liabilities | $102.5M | - | - |
| Shareholders Equity | $256.6M | - | - |
| Operating Cash Flow | $-98.7M | - | - |
| Capital Expenditures | $607,000 | - | - |